BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 26987432)

  • 1. Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway.
    Franiak-Pietryga I; Maciejewski H; Ostrowska K; Appelhans D; Voit B; Misiewicz M; Kowalczyk P; Bryszewska M; Borowiec M
    Int J Biol Macromol; 2016 Jul; 88():156-61. PubMed ID: 26987432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Maciejewski H; Voit B; Kaczmarek A; Robak T; Klajnert-Maculewicz B; Cebula-Obrzut B; Smolewski P; Borowiec M; Bryszewska M
    Anticancer Agents Med Chem; 2017; 17(1):102-114. PubMed ID: 27349446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.
    Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Voit B; Szewczyk M; Góra-Tybor J; Robak T; Klajnert B; Bryszewska M
    Mol Pharm; 2013 Jun; 10(6):2490-501. PubMed ID: 23641871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles.
    Franiak-Pietryga I; Ostrowska K; Maciejewski H; Ziemba B; Appelhans D; Voit B; Jander M; Treliński J; Bryszewska M; Borowiec M
    Toxicol Appl Pharmacol; 2018 Oct; 357():33-38. PubMed ID: 30125597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPI-G4 Glycodendrimers Upregulate TRAIL-Induced Apoptosis in Chronic Lymphocytic Leukemia Cells.
    Franiak-Pietryga I; Ostrowska K; Maciejewski H; Appelhans D; Misiewicz M; Ziemba B; Bednarek M; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 May; 17(5):. PubMed ID: 27996200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maltotriose-modified poly(propylene imine) Glycodendrimers as a potential novel platform in the treatment of chronic lymphocytic Leukemia. A proof-of-concept pilot study in the animal model of CLL.
    Franiak-Pietryga I; Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Lewkowicz P; Ostrowska K; Bryszewska M; Borowiec M
    Toxicol Appl Pharmacol; 2020 Sep; 403():115139. PubMed ID: 32687837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.
    Franiak-Pietryga I; Maciejewski H; Ziemba B; Appelhans D; Voit B; Robak T; Jander M; Treliński J; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28762636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
    Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Bryszewska M; Borowiec M; Franiak-Pietryga I
    Anticancer Agents Med Chem; 2020; 20(3):325-334. PubMed ID: 31738155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells.
    Pallasch CP; Schwamb J; Königs S; Schulz A; Debey S; Kofler D; Schultze JL; Hallek M; Ultsch A; Wendtner CM
    Leukemia; 2008 Mar; 22(3):585-92. PubMed ID: 18079738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
    Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
    Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation.
    Rodríguez A; Villuendas R; Yáñez L; Gómez ME; Díaz R; Pollán M; Hernández N; de la Cueva P; Marín MC; Swat A; Ruiz E; Cuadrado MA; Conde E; Lombardía L; Cifuentes F; Gonzalez M; García-Marco JA; Piris MA;
    Leukemia; 2007 Sep; 21(9):1984-91. PubMed ID: 17611561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.
    Ziemba B; Halets I; Shcharbin D; Appelhans D; Voit B; Pieszynski I; Bryszewska M; Klajnert B
    J Biomed Mater Res A; 2012 Nov; 100(11):2870-80. PubMed ID: 22623362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(propylene imine) dendrimers modified with maltose or maltotriose protect phosphorothioate oligodeoxynucleotides against nuclease activity.
    Drzewińska J; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biochem Biophys Res Commun; 2012 Oct; 427(1):197-201. PubMed ID: 22995301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
    Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
    Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation.
    Burger JA; Quiroga MP; Hartmann E; Bürkle A; Wierda WG; Keating MJ; Rosenwald A
    Blood; 2009 Mar; 113(13):3050-8. PubMed ID: 19074730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transcriptional regulation of inducible nitric oxide synthase in chronic lymphocytic leukemia B cells in pro- and antiapoptotic culture conditions.
    Tiscornia AC; Cayota A; Landoni AI; Brito C; Oppezzo P; Vuillier F; Robello C; Dighiero G; Gabús R; Pritsch O
    Leukemia; 2004 Jan; 18(1):48-56. PubMed ID: 14574328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for distinct pathomechanisms in genetic subgroups of chronic lymphocytic leukemia revealed by quantitative expression analysis of cell cycle, activation, and apoptosis-associated genes.
    Kienle DL; Korz C; Hosch B; Benner A; Mertens D; Habermann A; Kröber A; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    J Clin Oncol; 2005 Jun; 23(16):3780-92. PubMed ID: 15867199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia.
    Saint-Georges S; Quettier M; Bouyaba M; Le Coquil S; Laurienté V; Guittat L; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N; Le Roy C; Ledoux D
    Oncotarget; 2016 Jul; 7(27):41031-41046. PubMed ID: 27127886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of reactive oxygen species-mediated signal transduction with in vitro apoptosis sensitivity in chronic lymphocytic leukemia B cells.
    Palazzo AL; Evensen E; Huang YW; Cesano A; Nolan GP; Fantl WJ
    PLoS One; 2011; 6(10):e24592. PubMed ID: 22016760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxicity of poly(propylene imine) dendrimers.
    Ziemba B; Matuszko G; Appelhans D; Voit B; Bryszewska M; Klajnert B
    Biopolymers; 2012 Aug; 97(8):642-8. PubMed ID: 22605555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.